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ukaryotic cells are great recyclers. 
When proteins or organelles be-
come damaged or obsolete, cells 
don’t leave this garbage lying around. 
Instead, the autophagy pathway kicks in to 
corral it and bring it to the cell’s lysosomes, 
where it’s broken down into parts that can 
be reused elsewhere in the cell. Such cel-
lular recycling not only keeps things tidy, 
says Noboru Mizushima, it also is impor-
tant for cellular and organismal survival. 
He should know, because he’s been at the 
forefront of autophagy research since fi  rst 
encountering it during his postdoctoral 
studies with Dr. Yoshinori Ohsumi at the 
National Institute for Basic Biology in 
Okazaki, Japan (1).
First trained as a physician, Mizushima 
encountered autophagy almost by acci-
dent when he read about the burgeoning 
young fi  eld in a Japanese-language sci-
ence magazine. Since then, he’s made it 
his life’s work to understand how this pro-
cess works (2, 3), when it is used (4, 5), 
and the consequences of its 
dysregulation (6). We reached 
him at his offi  ce at Tokyo 
Medical and Dental Univer-
sity to discuss some of the 
choices he’s made in his ca-
reer, and why cells sometimes 
choose to eat themselves.
HARD CHOICE
As a child, did you know 
what you wanted to be 
when you grew up?
Growing up in Tokyo, I was 
very infl  uenced by my father 
and my grandfather. My father was a medi-
cal doctor and a scientist. He saw patients 
every week, but he was also very interested 
in drug development. On the other hand, 
my grandfather was a physicist. I couldn’t 
understand everything he worked on, but 
he was doing atomic science. I admired 
them both very much, so I wanted to be 
either a scientist or medical doctor. I didn’t 
decide between the two until much later.
Did you have much exposure to 
biological science in school?
When I was in high school, I was most 
interested in physics and chemistry. I 
didn’t have much time for biology until I 
went to medical school at Tokyo Medical 
and Dental University.
In Japan, we don’t do four years of 
university followed by four years of 
medical school like they do in the United 
States. We just have a combined six-year 
program for medical school. While I was 
an undergraduate in medical school, I 
became very interested in immunology 
and basic research. Then I started think-
ing I would rather be a scientist than a 
medical doctor.
But you went through your clinical 
training anyway?
Yes, and I am very glad that I did because 
seeing patients had a strong infl  uence on 
me. Until that time, I hadn’t thought very 
much about whole-body systems, but after 
my clinical training I became 
very interested in autoim-
mune diseases. They’re very 
diffi  cult to treat, but also 
very interesting because 
patients show a lot of dif-
ferent symptoms. That is 
why I decided to do a PhD 
in immunology, working 
on T-cell immunology and 
autoimmune disease.
Was that an unusual 
career choice to make?
Most Japanese students go 
to a medical or clinical department after 
fi   nishing their clinical training. I think 
this is a serious problem—we have very 
few MD scientists in Japan, and the 
number is decreasing. One thing we could 
do to address this problem is to provide 
more opportunities for research during 
medical school.
I am always encouraging medical stu-
dents in my classes to consider becoming 
basic scientists. We also have a few stu-
dents working in my lab, and we have 
tried to provide them with as many oppor-
tunities as possible. It is important that 
they get this kind of exposure.
BIG CHOICE
After completing your PhD, did you 
consider returning to medicine?
That was a critical point in my career. I 
thought it would be very diffi  cult for me 
to work as a scientist and as a medical 
doctor. Both careers were very interesting 
to me, but fi  nally I decided to focus on 
basic science. I gave up my medical activi-
ties when I started my postdoc.
That is when you ﬁ  rst started working 
on autophagy?
Yes. That was a dramatic shift for me, 
because I’d been in a medical depart-
ment and I moved to a yeast research 
laboratory. I think there were three rea-
sons I made that move. First, I thought 
immunology was interesting, but the 
immune system is so complicated that I 
thought it would be very diffi  cult for me 
to understand everything about it. The 
second reason is that I felt it would be 
hard to survive in an established fi  eld 
like immunology. I wanted to go into a 
new, less established research area so 
that I could catch up to others in the fi  eld. 
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The third reason was that I was interested 
in protein recycling and turnover.
I was very lucky to fi  nd Dr. Ohsumi’s 
laboratory, where I did my postdoctoral 
work. At the time, I applied to several 
laboratories in the United States and other 
countries. I had never heard anything 
about autophagy, but I happened to read a 
very short article about it in a Japanese 
science magazine. I quickly decided that 
that was what I wanted to study.
You helped characterize many 
components of the yeast autophagy 
pathway, like Apg12?
When I joined Dr. Ohsumi’s 
laboratory, they had already 
cloned many autophagy 
genes. Most of them were 
new genes whose function 
could not be simply predicted 
from their sequences. I don’t 
remember why I picked 
Apg12, but probably it was 
just because nobody else was 
working on it yet.
The exact function of this 
protein remains unknown, 
but it is probably important 
for elongation of the isolation membrane. 
The isolation membrane is an intermedi-
ate structure during autophagosome for-
mation, in which membrane is extruded 
until it encloses a portion of cytoplasm. 
We couldn’t actually ob-
serve the process of isola-
tion membrane formation 
until I started studying 
autophagy in mammalian 
cells. In yeast everything 
is very tiny; it’s very dif-
fi  cult to see things like the 
elongation step in yeast 
cells. In mammalian cells 
it is much easier.
CHOICE PROBLEMS
How have your studies on 
autophagy branched out 
since your postdoc work?
A major focus of my lab 
has been using mouse ge-
netics to explore the physio-
logical roles of auto  phagy. For example, 
we have found that autophagy is impor-
tant during embryogenesis. Soon after 
fertilization but before implantation, ferti-
lized eggs must convert maternal proteins 
into embryonic proteins. They do this by 
degrading maternal proteins via auto-
phagy, and recycling the amino acids to 
make embryonic proteins.
Autophagy is also important later on, 
in the neonatal stage. During embryo-
genesis, embryos get nutrients from 
their mother. But after birth, before they 
begin nursing, they have to survive by 
themselves. We know that autophagy is 
important for adaptation 
to starvation conditions; 
it lets us degrade our own 
proteins when we don’t 
have access to external 
nutrients. We can eat our-
selves to survive. So, in 
the fi   rst few hours after 
birth, neonates use auto-
phagy to degrade parts of 
themselves very quickly 
to produce energy and nec-
essary nutrients.
Finally, we know that 
autophagy is important for the clearance 
of abnormal intracellular proteins and 
organelles. This may be especially impor-
tant in the context of degenerative condi-
tions like Huntington’s, Alzheimer’s, or 
Parkinson’s disease. There may be other 
autophagy-related diseases that haven’t 
yet been identifi  ed.
What other problems are you working 
on now?
Another focus of my lab is the mecha-
nisms by which autophagy is regulated. 
There are only 30 autophagy genes that 
directly make up the autophagy pathway, 
but there are a lot of additional genes and 
pathways involved in regulating auto-
phagic activity. We are trying to under-
stand these regulatory pathways. Finally, 
we are also interested in where and how 
the autophagosome is formed. Our hypoth-
esis is that autophagosomes are generated 
on a particular domain of the endoplasmic 
reticulum, because many autophagy pro-
teins accumulate there.
We are doing a lot of things in my lab: 
cell biology, embryology, neurobiology, 
metabolism, and endocrinology. Some-
times people advise me to focus on some-
thing, to work on a very limited fi  eld. But 
I think a trans-disciplinary approach is 
very important, because really I am focus-
ing on just one keyword: autophagy. That 
is what I enjoy.
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Autophagosomes (green) in a fertilized oocyte.
“There may 
be other 
autophagy-
related 
diseases 
that haven’t 
yet been 
identified.”
Mizushima discussing basic science with 
undergraduates.